These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22672778)

  • 1. Predicting later-life outcomes of early-life exposures.
    Boekelheide K; Blumberg B; Chapin RE; Cote I; Graziano JH; Janesick A; Lane R; Lillycrop K; Myatt L; States JC; Thayer KA; Waalkes MP; Rogers JM
    Environ Health Perspect; 2012 Oct; 120(10):1353-61. PubMed ID: 22672778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asking the right questions: how early-life exposures influence later development of disease.
    Barrett JR
    Environ Health Perspect; 2012 Oct; 120(10):a403. PubMed ID: 23026485
    [No Abstract]   [Full Text] [Related]  

  • 3. The die is cast: arsenic exposure in early life and disease susceptibility.
    Thomas DJ
    Chem Res Toxicol; 2013 Dec; 26(12):1778-81. PubMed ID: 24191665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero and early life arsenic exposure in relation to long-term health and disease.
    Farzan SF; Karagas MR; Chen Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):384-90. PubMed ID: 23859881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.
    Kaushal A; Zhang H; Karmaus WJJ; Everson TM; Marsit CJ; Karagas MR; Tsai SF; Wen HJ; Wang SL
    Environ Health; 2017 May; 16(1):50. PubMed ID: 28558807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Life Arsenic Exposure, Nutritional Status, and Adult Diabetes Risk.
    Navas-Acien A; Spratlen MJ; Abuawad A; LoIacono NJ; Bozack AK; Gamble MV
    Curr Diab Rep; 2019 Nov; 19(12):147. PubMed ID: 31758285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prenatal arsenic exposure on chronic adult diseases.
    Young JL; Cai L; States JC
    Syst Biol Reprod Med; 2018 Dec; 64(6):469-483. PubMed ID: 29873257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring.
    Vrachnis N; Antonakopoulos N; Iliodromiti Z; Dafopoulos K; Siristatidis C; Pappa KI; Deligeoroglou E; Vitoratos N
    Exp Diabetes Res; 2012; 2012():538474. PubMed ID: 23227034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome.
    Bailey K; Fry RC
    Rev Environ Health; 2014; 29(1-2):9-12. PubMed ID: 24552957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models.
    Patti ME
    Cell Mol Life Sci; 2013 May; 70(9):1597-608. PubMed ID: 23435955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauterine environment.
    El Hajj N; Schneider E; Lehnen H; Haaf T
    Reproduction; 2014 Dec; 148(6):R111-20. PubMed ID: 25187623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Early Growth and Age-Associated Disease.
    Tarry-Adkins JL; Ozanne SE
    Subcell Biochem; 2019; 91():1-19. PubMed ID: 30888647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of early life programming: current knowledge and future directions.
    Tarry-Adkins JL; Ozanne SE
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1765S-1771S. PubMed ID: 21543536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Health Effects and Underlying Biological Mechanisms of Developmental Exposure to Arsenic.
    Smeester L; Fry RC
    Curr Environ Health Rep; 2018 Mar; 5(1):134-144. PubMed ID: 29411302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental origins of type 2 diabetes: a perspective from China.
    Ma RCW; Tsoi KY; Tam WH; Wong CKC
    Eur J Clin Nutr; 2017 Jul; 71(7):870-880. PubMed ID: 28378847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic basis for fetal origins of age-related disease.
    Thompson RF; Einstein FH
    J Womens Health (Larchmt); 2010 Mar; 19(3):581-7. PubMed ID: 20136551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine programming of obesity and type 2 diabetes.
    Fernandez-Twinn DS; Hjort L; Novakovic B; Ozanne SE; Saffery R
    Diabetologia; 2019 Oct; 62(10):1789-1801. PubMed ID: 31451874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nutrition during early life on the epigenetic regulation of transcription and implications for human diseases.
    Lillycrop KA; Burdge GC
    J Nutrigenet Nutrigenomics; 2011; 4(5):248-60. PubMed ID: 22353662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In utero arsenic exposure in mice and early life susceptibility to cancer.
    Garry MR; Santamaria AB; Williams AL; DeSesso JM
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):378-90. PubMed ID: 26239692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics and DOHaD: from basics to birth and beyond.
    Bianco-Miotto T; Craig JM; Gasser YP; van Dijk SJ; Ozanne SE
    J Dev Orig Health Dis; 2017 Oct; 8(5):513-519. PubMed ID: 28889823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.